The U.S. Food and Drug Administration (FDA) has placed a clinical hold on Kezar Life Sciences’ zetomipzomib, an ...

In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

A support group is a gathering of people facing common issues to share what’s troubling them. Through the sharing of experiences, they can offer support, encouragement, and comfort to the other group ...

New study finds that Black children and those identifying with more than one race have higher disease activity and are less likely to achieve low lupus disease activity state compared to White ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...